Abstract
Methods
In 24 outpatients with HCM at a single, referral center, the KCCQ instrument was administered and cardiopulmonary exercise
testing (CPX) was performed. Severity of symptoms as determined by physician (NYHA classification) and patient (KCCQ instrument)
was obtained before exercise test results were known. Pearson correlation was used to assess the independent correlation between
KCCQ score and the various exercise parameters; Spearman correlation was used to assess correlation between KCCQ score and
NYHA class.
testing (CPX) was performed. Severity of symptoms as determined by physician (NYHA classification) and patient (KCCQ instrument)
was obtained before exercise test results were known. Pearson correlation was used to assess the independent correlation between
KCCQ score and the various exercise parameters; Spearman correlation was used to assess correlation between KCCQ score and
NYHA class.
Results
KCCQ results demonstrated moderate reductions in all domains, with greatest reduction in quality-of-life domain. CPX testing
showed reduction in peak oxygen consumption (mean absolute VO2 20.5 ± 7.8 ml/kg/min and percent predicted VO2 76.8 ± 4.1 %).
There were negative correlations between NYHA class and all KCCQ components except the self-efficacy score. The strongest
correlations were between NYHA class and the overall summary score (r = −0.623, p = 0.001) as well as the physical limitation score (r = −0.604, p = 0.002). Similarly, there were statistically significant positive correlations between the KCCQ components and percent predicted
peak VO2. The strongest correlation was between percent predicted peak VO2 and the physical limitation score (r = 0.474, p = 0.019), but there was also correlation between percent predicted peak VO2 and the quality-of-life score (r = 0.456, p = 0.025), the functional status score (r = 0.455, p = 0.025), and the clinical summary score (r = 0.444, p = 0.030).
showed reduction in peak oxygen consumption (mean absolute VO2 20.5 ± 7.8 ml/kg/min and percent predicted VO2 76.8 ± 4.1 %).
There were negative correlations between NYHA class and all KCCQ components except the self-efficacy score. The strongest
correlations were between NYHA class and the overall summary score (r = −0.623, p = 0.001) as well as the physical limitation score (r = −0.604, p = 0.002). Similarly, there were statistically significant positive correlations between the KCCQ components and percent predicted
peak VO2. The strongest correlation was between percent predicted peak VO2 and the physical limitation score (r = 0.474, p = 0.019), but there was also correlation between percent predicted peak VO2 and the quality-of-life score (r = 0.456, p = 0.025), the functional status score (r = 0.455, p = 0.025), and the clinical summary score (r = 0.444, p = 0.030).
Conclusions
The multiple domains of the KCCQ provide data on patient-perceived health status, which correlate with physician-perceived
and objective measurement of functional capacity in HCM. Additional studies are needed to evaluate the sensitivity of the
KCCQ to changes in functional capacity over time or in response to therapies for this condition.
and objective measurement of functional capacity in HCM. Additional studies are needed to evaluate the sensitivity of the
KCCQ to changes in functional capacity over time or in response to therapies for this condition.
- Content Type Journal Article
- Pages 1-6
- DOI 10.1007/s11136-012-0182-y
- Authors
- Christopher M. Huff, Cleveland Clinic Heart and Vascular Institute, Cleveland, OH, USA
- Aslan T. Turer, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA
- Andrew Wang, Department of Medicine, Duke University Medical Center, DUMC 3428, Durham, NC 27710, USA
- Journal Quality of Life Research
- Online ISSN 1573-2649
- Print ISSN 0962-9343